| Name | sphingosine kinase 2 |
| Description | This gene encodes one of two sphingosine kinase isozymes that catalyze the phosphorylation of sphingosine into sphingosine 1-phosphate. Sphingosine 1-phosphate mediates many cellular processes including migration, proliferation and apoptosis, and also plays a role in several types of cancer by promoting angiogenesis and tumorigenesis. The encoded protein may play a role in breast cancer proliferation and chemoresistance. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2011] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSphingosine kinase‐2 (SPHK2) is a versatile lipid kinase that catalyzes the phosphorylation of sphingosine to produce sphingosine‑1‑phosphate (S1P), a bioactive mediator whose actions depend strongly on subcellular localization and post‑translational modifications. SPHK2 not only mediates the in vivo activation of pharmacologic agents such as FTY720 [1], but also exists in distinct splice variants, with one major human isoform (SPHK2‑L) that translocates into the nucleus upon cellular stress or serum deprivation, thereby influencing DNA synthesis and apoptosis [2]. Furthermore, extracellular signals like epidermal growth factor (EGF) and activators such as phorbol ester initiate rapid phosphorylation of SPHK2 via kinases including ERK1 and protein kinase D, leading to enhanced enzymatic activity and regulated nuclear export [3], [4], [5], [12]."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nIn cancer models, SPHK2 plays multifaceted roles that contribute to tumor cell survival, migration, and chemoresistance. Inhibition of SPHK2 by selective agents (for example, ABC294640 or the SPHK2‐selective analogue (R)‑FTY720‑OMe) reduces survival signaling pathways, diminishes NF‑κB activation, and induces apoptosis in several malignancies including chemo‑ and endocrine‑resistant breast cancer [11], as well as in prostate and viral‑associated lymphomas [9], [10], [13]. In parallel, studies in colon and non‑small cell lung cancer indicate that SPHK2 modulates ceramide metabolism and anti‑apoptotic signaling (via Akt, ERK, and p53/p21 pathways), making its inhibition a promising strategy to overcome drug resistance [14], [16], [17], [19], [23], [34]."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "16"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its classical catalytic function, SPHK2 is subject to intricate regulation by factors including microRNAs, mRNA methylation, and interacting proteins that modulate its expression, localization, and activity. For instance, miR‑613 and miR‑363‑3p directly target SPHK2 mRNA to suppress tumor cell growth in papillary thyroid and colorectal cancers, respectively [21], [15]. SPHK2 also cooperates with enzymes involved in sphingolipid salvage pathways [6] and is regulated by protein partners such as eEF1A, which enhances its catalytic rate [8]. These regulatory mechanisms extend to non‑malignant settings, as observed in osteoarthritis chondrocytes [25] and in exosome biogenesis, where SPHK2 knockdown leads to a reduction in oncogenic microRNA sorting that may attenuate tumorigenesis [29], [28]."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "24"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nSPHK2’s broad pathophysiological relevance is further underscored by its involvement in several non‑cancerous disorders. In conditions such as renal fibrosis and pancreatic cancer, SPHK2‐mediated signaling (via downstream effectors including Fyn, STAT3, and AKT) promotes extracellular matrix production and tumor progression [24], [26], [27], [30], [31], [32], [33]. In addition, SPHK2 regulates inflammatory responses in human macrophages [35] and partakes in neuroblastoma cell differentiation and stemness via crosstalk with adrenergic and S1P receptor pathways [36]. Collectively, these findings reveal that SPHK2 can exert both pro‑survival and pro‑apoptotic effects depending on its expression level, interacting partners, and subcellular distribution, thereby positioning it as an attractive therapeutic target across a spectrum of diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "25", "end_ref": "33"}]}]}]}]}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Steven W Paugh, Shawn G Payne, Suzanne E Barbour, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0014-5793(03)01168-2"}], "href": "https://doi.org/10.1016/s0014-5793(03"}, {"type": "t", "text": "01168-2) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14596938"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14596938"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Nitai C Hait, Sukumar Sarkar, Hervé Le Stunff, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of sphingosine kinase 2 in cell migration toward epidermal growth factor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M502922200"}], "href": "https://doi.org/10.1074/jbc.M502922200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15951439"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15951439"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Taro Okada, Guo Ding, Hirofumi Sonoda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M504507200"}], "href": "https://doi.org/10.1074/jbc.M504507200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16103110"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16103110"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Nitai C Hait, Andrea Bellamy, Sheldon Milstien, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sphingosine kinase type 2 activation by ERK-mediated phosphorylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M609559200"}], "href": "https://doi.org/10.1074/jbc.M609559200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17311928"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17311928"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Guo Ding, Hirofumi Sonoda, Huan Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein kinase D-mediated phosphorylation and nuclear export of sphingosine kinase 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M701641200"}], "href": "https://doi.org/10.1074/jbc.M701641200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17635916"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17635916"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Keng Gat Lim, Chaode Sun, Robert Bittman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "(R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2011.05.010"}], "href": "https://doi.org/10.1016/j.cellsig.2011.05.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21620961"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21620961"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Satoshi Nemoto, Mitsuhiro Nakamura, Yosuke Osawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M900735200"}], "href": "https://doi.org/10.1074/jbc.M900735200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19240026"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19240026"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Andreas Weigert, Sarah Cremer, Martina Victoria Schmidt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2009-10-243444"}], "href": "https://doi.org/10.1182/blood-2009-10-243444"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20197547"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20197547"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "James W Antoon, Martin D White, Evelyn M Slaughter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cbt.11.7.14903"}], "href": "https://doi.org/10.4161/cbt.11.7.14903"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21307639"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21307639"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Zhiqiang Qin, Lu Dai, Jimena Trillo-Tinoco, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-13-0466"}], "href": "https://doi.org/10.1158/1535-7163.MCT-13-0466"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24140934"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24140934"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Lan Dai, Yanfei Qi, Jinbiao Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sphingosine kinase (SphK) 1 and SphK2 play equivalent roles in mediating insulin's mitogenic action."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2013-1237"}], "href": "https://doi.org/10.1210/me.2013-1237"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24422628"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24422628"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Min Xiao, Yun Gang Liu, Meng Chen Zou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sodium butyrate induces apoptosis of human colon cancer cells by modulating ERK and sphingosine kinase 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Environ Sci (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3967/bes2014.040"}], "href": "https://doi.org/10.3967/bes2014.040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24709100"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24709100"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Lu Dai, Karlie Plaisance-Bonstaff, Christina Voelkel-Johnson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sphingosine kinase-2 maintains viral latency and survival for KSHV-infected endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0102314"}], "href": "https://doi.org/10.1371/journal.pone.0102314"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25010828"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25010828"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Wei Liu, Jinfeng Ning, Chunhong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of Sphk2 is associated with gefitinib resistance in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-4480-1"}], "href": "https://doi.org/10.1007/s13277-015-4480-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26628299"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26628299"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Aparna Maiti, Kazuaki Takabe, Nitai C Hait "}, {"type": "b", "children": [{"type": "t", "text": "Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2017.01.021"}], "href": "https://doi.org/10.1016/j.cellsig.2017.01.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28108260"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28108260"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Li Feng, Bin Yang, Xiao-Di Tang "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA LINC00460 promotes carcinogenesis via sponging miR-613 in papillary thyroid carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.27799"}], "href": "https://doi.org/10.1002/jcp.27799"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30478856"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30478856"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Hervé Le Stunff, Paola Giussani, Michael Maceyka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Recycling of sphingosine is regulated by the concerted actions of sphingosine-1-phosphate phosphohydrolase 1 and sphingosine kinase 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M703329200"}], "href": "https://doi.org/10.1074/jbc.M703329200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17895250"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17895250"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Tamara M Leclercq, Paul A B Moretti, Mathew A Vadas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M708782200"}], "href": "https://doi.org/10.1074/jbc.M708782200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18263879"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18263879"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Wangwang Qiu, Zhili Yang, Youben Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9530"}], "href": "https://doi.org/10.18632/oncotarget.9530"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27223438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27223438"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Craig T Wallington-Beddoe, Jason A Powell, Daochen Tong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-13-2732"}], "href": "https://doi.org/10.1158/0008-5472.CAN-13-2732"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24686171"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24686171"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Baasanjav Uranbileg, Hitoshi Ikeda, Makoto Kurano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0149462"}], "href": "https://doi.org/10.1371/journal.pone.0149462"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26886371"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26886371"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "K-C Xue, D-D Hu, L Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2017)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28975989"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28975989"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jinying Liang, Xinxin Zhang, Shufang He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sphk2 RNAi nanoparticles suppress tumor growth via downregulating cancer cell derived exosomal microRNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Control Release (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jconrel.2018.07.039"}], "href": "https://doi.org/10.1016/j.jconrel.2018.07.039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30077738"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30077738"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Shanmugam Panneer Selvam, Braden M Roth, Rose Nganga, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA118.003506"}], "href": "https://doi.org/10.1074/jbc.RA118.003506"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29748384"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29748384"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Stephanie Schwalm, Sandra Beyer, Helena Frey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sphingosine Kinase-2 Deficiency Ameliorates Kidney Fibrosis by Up-Regulating Smad7 in a Mouse Model of Unilateral Ureteral Obstruction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajpath.2017.06.017"}], "href": "https://doi.org/10.1016/j.ajpath.2017.06.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28807595"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28807595"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Dan-Dan Song, Jun-Hao Zhou, Rui Sheng "}, {"type": "b", "children": [{"type": "t", "text": "Regulation and function of sphingosine kinase 2 in diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histol Histopathol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14670/HH-11-939"}], "href": "https://doi.org/10.14670/HH-11-939"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29057430"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29057430"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Gaëlle Dominguez, Marie-Lise Maddelein, Mélanie Pucelle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer's disease brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neuropathol Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40478-018-0527-z"}], "href": "https://doi.org/10.1186/s40478-018-0527-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29615132"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29615132"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Xingxing Zhu, Dongyan Shi, Kelei Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sphingosine kinase 2 cooperating with Fyn promotes kidney fibroblast activation and fibrosis via STAT3 and AKT."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Mol Basis Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbadis.2018.09.007"}], "href": "https://doi.org/10.1016/j.bbadis.2018.09.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30251698"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30251698"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Ziyu Song, Wei Wang, Ning Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sphingosine kinase 2 promotes lipotoxicity in pancreatic β-cells and the progression of diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.201801496R"}], "href": "https://doi.org/10.1096/fj.201801496R"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30452878"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30452878"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Leili Hasanifard, Roghayeh Sheervalilou, Maryam Majidinia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New insights into the roles and regulation of SphK2 as a therapeutic target in cancer chemoresistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.27612"}], "href": "https://doi.org/10.1002/jcp.27612"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30456838"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30456838"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Kizuki Yuza, Masato Nakajima, Masayuki Nagahashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Surg Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jss.2018.06.019"}], "href": "https://doi.org/10.1016/j.jss.2018.06.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30463717"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30463717"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Juan Xiao, Houmin Lin, Binggang Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decreased S1P and SPHK2 are involved in pancreatic acinar cell injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomark Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/bmm-2018-0404"}], "href": "https://doi.org/10.2217/bmm-2018-0404"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31157539"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31157539"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Gennaro Bruno, Francesca Cencetti, Alessandro Pini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "β3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "2"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": " modulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-019-0993-1"}], "href": "https://doi.org/10.1038/s41388-019-0993-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31477835"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31477835"}]}]}]}
|
| Synonyms | SK 2, SPK 2, SK-2, SPK-2 |
| Proteins | SPHK2_HUMAN |
| NCBI Gene ID | 56848 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SPHK2 has 7,463 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 121 datasets.
Click the + buttons to view associations for SPHK2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SPHK2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SPHK2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SPHK2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SPHK2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SPHK2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SPHK2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SPHK2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SPHK2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SPHK2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SPHK2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SPHK2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with SPHK2 protein from the CCLE Cell Line Proteomics dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SPHK2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SPHK2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SPHK2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SPHK2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SPHK2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SPHK2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SPHK2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SPHK2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SPHK2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SPHK2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SPHK2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SPHK2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of SPHK2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SPHK2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SPHK2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SPHK2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SPHK2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SPHK2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SPHK2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SPHK2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SPHK2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SPHK2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SPHK2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SPHK2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SPHK2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SPHK2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SPHK2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SPHK2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SPHK2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SPHK2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SPHK2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SPHK2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SPHK2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SPHK2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SPHK2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SPHK2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing SPHK2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing SPHK2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SPHK2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SPHK2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SPHK2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SPHK2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SPHK2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SPHK2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SPHK2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SPHK2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding SPHK2 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SPHK2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SPHK2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for SPHK2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SPHK2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SPHK2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SPHK2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for SPHK2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HumanCyc Pathways | pathways involving SPHK2 protein from the HumanCyc Pathways dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SPHK2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SPHK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SPHK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SPHK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate SPHK2 protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways | pathways involving SPHK2 protein from the KEGG Pathways dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate SPHK2 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Kinase Library Tyrosine Kinome Atlas | kinases that phosphorylate SPHK2 protein from the Kinase Library Tyrosine Kinome Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SPHK2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of SPHK2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SPHK2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SPHK2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SPHK2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SPHK2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SPHK2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SPHK2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SPHK2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SPHK2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SPHK2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SPHK2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SPHK2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for SPHK2 protein from the MW Gene Metabolite Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SPHK2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing SPHK2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| PANTHER Pathways | pathways involving SPHK2 protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SPHK2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SPHK2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SPHK2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SPHK2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SPHK2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with SPHK2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate SPHK2 protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| PID Pathways | pathways involving SPHK2 protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving SPHK2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving SPHK2 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SPHK2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of SPHK2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SPHK2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SPHK2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SPHK2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SPHK2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of SPHK2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of SPHK2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SPHK2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SPHK2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SPHK2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SPHK2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SPHK2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SPHK2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SPHK2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SPHK2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SPHK2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving SPHK2 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SPHK2 protein from the WikiPathways Pathways 2024 dataset. | |